Pacific Biosciences of California Inc
NASDAQ:PACB

Watchlist Manager
Pacific Biosciences of California Inc Logo
Pacific Biosciences of California Inc
NASDAQ:PACB
Watchlist
Price: 2.58 USD -3.37% Market Closed
Market Cap: $778.9m

Net Margin

-325.8%
Current
Declining
by 82.3%
vs 3-y average of -243.5%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-325.8%
=
Net Income
$-503.6m
/
Revenue
$154.6m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-325.8%
=
Net Income
$-503.6m
/
Revenue
$154.6m

Peer Comparison

Country Company Market Cap Net
Margin
US
Pacific Biosciences of California Inc
NASDAQ:PACB
778.8m USD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.4B USD
Loading...
US
Danaher Corp
NYSE:DHR
166B USD
Loading...
CH
Lonza Group AG
SIX:LONN
37.6B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.3B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.7B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR
Loading...

Market Distribution

Lower than 90% of companies in the United States of America
Percentile
10th
Based on 15 072 companies
10th percentile
-325.8%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Pacific Biosciences of California Inc
Glance View

Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. The company is headquartered in Menlo Park, California and currently employs 728 full-time employees. The company went IPO on 2010-10-27. The firm designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. The firm has developed its Single Molecule, Real-Time (SMRT) technology, which enables single molecule, real-time detection of nucleic acid sequences, to address many of the limitations of previous sequencing technologies. The Company’s products include Sequel, Sequel II and Sequel IIe instruments and SMRT Cell 8M, which together can sequence up to approximately eight million deoxyribonucleic acid (DNA) molecules simultaneously, and the previous generation Sequel instrument and Sequel SMRT Cell 1M, which together conduct, monitor, and analyze single molecule biochemical reactions in real time. The firm's Sequel IIe System increases computational capacity and is designed to enable customers to generate PacBio HiFi reads.

PACB Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-325.8%
=
Net Income
$-503.6m
/
Revenue
$154.6m
What is Pacific Biosciences of California Inc's current Net Margin?

The current Net Margin for Pacific Biosciences of California Inc is -325.8%, which is below its 3-year median of -243.5%.

How has Net Margin changed over time?

Over the last 3 years, Pacific Biosciences of California Inc’s Net Margin has decreased from -218.4% to -325.8%. During this period, it reached a low of -431.7% on Mar 31, 2025 and a high of -148.1% on Mar 31, 2024.

Back to Top